How worried should you be about Ebola? Can the government lower drug prices without hurting the drug industry? And is socceromics a thing?

We chew over all that and more in the latest episode of “The Readout LOUD,” STAT’s biotech podcast. Wall Street analyst Brian Skorney calls in to explain his one weird trick to fix drug pricing, and STAT’s Helen Branswell stops by to catch us up on the latest Ebola outbreak — and the bold vaccination scheme underway to stop it. Then we talk about 23andMe’s arguably ill-conceived World Cup sponsorship and subject ourselves to another lightning round that quickly devolves into drinking sunscreen and shots of Fireball.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy